Considering that in the pan-cancer analysis, we found the most significant prognostic predictive effect of TMEindex in KIRC and BLCA, therefore we selected two anti-PD-L1 cohorts in kidney cancer and BLCA for validation. The gene discussed is CD274; the disease is kidney cancer.